Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03541902
Title Cabozantinib Versus Sunitinib for Metastatic Variant Histology Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

chromophobe renal cell carcinoma

renal cell carcinoma

papillary renal cell carcinoma

Therapies

Cabozantinib

Sunitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.